Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors

被引:96
|
作者
Sunderkoetter, C. [1 ]
Herrgott, I. [1 ]
Brueckner, C. [2 ]
Moinzadeh, P. [3 ]
Pfeiffer, C. [4 ]
Gerss, J. [5 ]
Hunzelmann, N. [3 ]
Boehm, M. [1 ]
Krieg, T. [3 ]
Mueller-Ladner, U. [6 ]
Genth, E. [7 ]
Schulze-Lohoff, E. [8 ]
Meurer, M. [4 ]
Melchers, I. [9 ]
Riemekasten, G. [2 ]
机构
[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany
[4] Dresden Univ Hosp, Dept Dermatol, Dresden, Germany
[5] Univ Munster, Coordinating Ctr Clin Trials, Dept Med Informat & Biomath, D-48149 Munster, Germany
[6] Univ Giessen, Kerckhoff Clin, Dept Rheumatol & Clin Immunol, Bad Nauheim, Germany
[7] Univ Aachen, D-5100 Aachen, Germany
[8] Hosp Cologne Merheim, Med Clin 1, Cologne, Germany
[9] Univ Med Ctr Freiburg, Clin Res Unit Rheumatol, Freiburg, Germany
关键词
digital ulcers; German Network; Raynaud's phenomenon; risk factors; systemic sclerosis; RAYNAUDS-PHENOMENON; GERMAN NETWORK; SCLERODERMA TRIALS; ILOPROST TREATMENT; DISEASE; PATHOPHYSIOLOGY; CONSEQUENCES; DERMATOLOGY; MULTICENTER; MANAGEMENT;
D O I
10.1111/j.1365-2133.2008.09004.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Digital ulcers (DU) are a major complication in the course of systemic sclerosis (SSc). In recent years, efficacious, but expensive therapies (e. g. iloprost, sildenafil, bosentan) have been shown to improve healing or to reduce the recurrence of DU. For optimal management it would be useful to identify the risk factors for DU. Such statistical analyses have been rare because they require a high number of patients. Objectives To identify potential risk factors for DU in patients with SSc. Methods We used the registry of the German Network for Systemic Scleroderma and evaluated the data of 1881 patients included by August 2007. We assessed potential risk factors for DU by comparing patients with (24.1%) and without active DU at time of entry (75.9%). Results Multivariate analysis revealed that male sex, presence of pulmonary arterial hypertension (PAH), involvement of the oesophagus, diffuse skin sclerosis (only when PAH was present), anti-Scl70 antibodies, young age at onset of Raynaud's phenomenon (RP), and elevated erythrocyte sedimentation rate (ESR) significantly impacted on the appearance of DU. Certain combinations increased the patients' probability of presenting with DU, with the highest probability (88%) for male patients with early onset of RP, ESR > 30 mm h(-1), anti-Scl70 antibodies and PAH. Patients with DU developed RP, skin sclerosis and organ involvement approximately 2-3 years earlier than patients without DU. Conclusions The results reveal possible risk factors for the occurrence of DU in SSc. As DU are prone to local complications, prophylactic vasoactive treatment for patients presenting with these factors may be justified.
引用
收藏
页码:835 / 843
页数:9
相关论文
共 50 条
  • [41] Bosentan For Digital Ulcers in Patients With Systemic Sclerosis: Single Center Experience
    Kucuksahin, Orhan
    Yildizgoren, Mustafa Turgut
    Gerede, Demet Menekse
    Maras, Yuksel
    Erten, Sukran
    ARCHIVES OF RHEUMATOLOGY, 2016, 31 (03): : 229 - 233
  • [42] Digital ulcers predict a worse disease course in patients with systemic sclerosis
    Mihai, Carina
    Landewe, Robert
    van der Heijde, Desiree
    Walker, Ulrich A.
    Constantin, Paul I.
    Gherghe, Ana Maria
    Ionescu, Ruxandra
    Rednic, Simona
    Allanore, Yannick
    Avouac, Jerome
    Czirjak, Laszlo
    Hachulla, Eric
    Riemekasten, Gabriela
    Cozzi, Franco
    Airo, Paolo
    Cutolo, Maurizio
    Mueller-Ladner, Ulf
    Matucci-Cerinic, Marco
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (04) : 681 - 686
  • [43] Angiogenic Biomarkers Predict the Development of Digital Ulcers in Patients with Systemic Sclerosis
    Avouac, Jerome
    Meune, Christophe
    Kahan, Andre
    Chiocchia, Gilles
    Allanore, Yannick
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S586 - S586
  • [44] Dysfunctional arteriovenous anastomoses in the hands of systemic sclerosis patients with digital ulcers
    Bergersen, T. K.
    Hoffmann-Vold, A. -M.
    Midtvedt, O.
    Gran, J. T.
    Mork, C.
    Toska, K.
    Elstad, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : S53 - S59
  • [45] Decreased prevalence of digital ulcers in patients with systemic sclerosis treated with SSRIs
    Lichtman, M.
    Kam, S.
    Damstetter, E.
    Mundluru, S.
    Besen, J.
    Lam, C.
    Cabral, H.
    Falanga, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S22 - S22
  • [46] Bosentan reduces the number of new digital ulcers in patients with systemic sclerosis
    Seibold, J. R.
    Matucci-Cerinic, M.
    Denton, C. P.
    Furst, D. E.
    Mayes, M. D.
    Kramer, F.
    Morganti, A.
    Korn, J. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 90 - 90
  • [47] TREATMENT OF DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS: PROSPECTIVE COHORT STUDY
    Chang, S. H.
    Jun, J. B.
    Lee, Y. J.
    Kang, T. Y.
    Park, Y.
    Lee, S. G.
    Lee, S. S.
    Lee, E. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 695 - 695
  • [48] Bosentan reduces the number of new digital ulcers in patients with systemic sclerosis
    Matucci-Cerinic, M.
    Denton, C. P.
    Furst, D. E.
    Mayes, M. D.
    Morganti, A.
    Kramer, F.
    Korn, J. H.
    Seibold, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A46 - A47
  • [49] GAZE PATTERN ANALYSIS IN THE ASSESSMENT OF DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Moser, Thomas
    Lohmeyer, Quentin
    Meboldt, Mirko
    Distler, Oliver
    Becker, Mike O.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1208 - 1208
  • [50] OSTEOMYELITIS COMPLICATING DIGITAL ULCERS IN SYSTEMIC SCLEROSIS
    Chiapparoli, I.
    Locatelli, F.
    Orsolini, P.
    Caporali, R.
    Montecucco, C.
    Codullo, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1519 - 1519